Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Florbetaben F18 - Piramal

Drug Profile

Florbetaben F18 - Piramal

Alternative Names: 18F-AV 1; 18F-AV1/ZK; [18F] florbetaben; AV-1; AV-1/ZK; BAY 94-9172; Florbetaben 18F; NeuraCeq; UNII-TLA7312TOI; ZK 6013443

Latest Information Update: 08 Jan 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Avid Radiopharmaceuticals
  • Developer Avid Radiopharmaceuticals; Bayer HealthCare Pharmaceuticals; Ci-Co Healthcare; Isologic Innovative Radiopharmaceuticals; PET Pharm Biotech; Piramal Enterprises
  • Class Aniline compounds; Radiopharmaceutical diagnostics; Small molecules
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Alzheimer's disease
  • No development reported Mild cognitive impairment

Most Recent Events

  • 28 Dec 2018 Keio University School of Medicine completes the clinical trial in Alzheimer's disease (Diagnosis, In volunteers) in Japan (UMIN000025420)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Mild-cognitive-impairment(Diagnosis) in Australia (IV, Injection)
  • 28 Feb 2017 Launched for Alzheimer's disease (Diagnosis) in Canada (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top